Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Charles Stanley Says Accumulate AstraZeneca

Tue, 11th Aug 2015 08:43

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning & Monday:
----------
FTSE 100
----------
CITIGROUP REMOVES ARM HOLDINGS FROM 'CITI FOCUS LIST EUROPE' - 'BUY'
----------
CITIGROUP RAISES RANDGOLD RESOURCES PRICE TARGET TO 4745 (4644) PENCE - 'BUY'
----------
JPMORGAN RAISES TRAVIS PERKINS PRICE TARGET TO 2550 (2300) PENCE - 'OVERWEIGHT'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1570) PENCE - 'HOLD'
----------
BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 440 (436) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS SCHRODERS PRICE TARGET TO 3400 (3500) PENCE - 'HOLD'
----------
S&P CAPITAL IQ RAISES INMARSAT TO 'HOLD' ('SELL') - TARGET 1000 (900) PENCE
----------
CHARLES STANLEY CUTS DIRECT LINE TO 'REDUCE' ('HOLD') - TARGET 330 (328) PENCE
----------
CHARLES STANLEY CUTS AVIVA PRICE TARGET TO 590 (615) PENCE - 'HOLD'
----------
CHARLES STANLEY CUTS HSBC PRICE TARGET TO 640 (650) PENCE - 'HOLD'
----------
CHARLES STANLEY RAISES ASTRAZENECA TO 'ACCUMULATE' ('HOLD')
----------
FTSE 250
----------
NUMIS CUTS LADBROKES PRICE TARGET TO 110 (140) PENCE - 'HOLD'
----------
TRADERS: PEEL HUNT RAISES MONEYSUPERMARKET.COM TO 'BUY' ('HOLD')
----------
NOMURA CUTS WILLIAM HILL PRICE TARGET TO 433 (443) PENCE - 'BUY'
----------
NOMURA RAISES BETFAIR PRICE TARGET TO 2094 (1838) PENCE - 'REDUCE'
----------
JPMORGAN CUTS ESURE GROUP PRICE TARGET TO 295 (299) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RESUMES KIER GROUP WITH 'OVERWEIGHT' - TARGET 1638 PENCE
----------
BARCLAYS CUTS ESURE GROUP PRICE TARGET TO 295 (300) PENCE - 'OVERWEIGHT'
----------
TRADERS: KEPLER CHEUVREUX CUTS ULTRA ELECTRONICS TO 'HOLD' ('BUY')
----------
TRADERS: MORGAN STANLEY CUTS KAZ MINERALS TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
TRADERS: MORGAN STANLEY RAISES BBA AVIATION TO 'EQUAL-WEIGHT' ('UNDERWEIGHT')
----------
RBC CAPITAL MARKETS RAISES BALFOUR BEATTY TO OUTPERFORM FROM SECTOR PERFORM
----------
MAIN MARKET AND AIM
----------
NUMIS CUTS JOHNSTON PRESS PRICE TARGET TO 115 (168) PENCE - 'HOLD'
----------
NUMIS CUTS ROTALA TO 'HOLD' ('ADD') - TARGET 74 (70) PENCE
----------
PANMURE CUTS PARTNERSHIP ASSURANCE TO 'HOLD' ('BUY') - TARGET 165 (175) PENCE
----------
LIBERUM RESUMES ROCKHOPPER EXPLORATION WITH 'BUY' - TARGET 138 PENCE
----------
Cantor Puts UK Mail Group At Hold From Under Review, Cuts Price Target To 450p From 590p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.